Jeannie Louie
Overview
Explore the profile of Jeannie Louie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
66
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazaki T, Gunderson A, Gilchrist M, Whiteford M, Kiely M, Hayman A, et al.
Lancet Oncol
. 2022 Aug;
23(9):1189-1200.
PMID: 35952709
Background: TGF-β is an immunosuppressive cytokine that is upregulated in colorectal cancer. TGF-β blockade improved response to chemoradiotherapy in preclinical models of colorectal adenocarcinoma. We aimed to test the hypothesis...
2.
Gannett D, Wolf R, Takahashi G, Louie J, Wagner R, Ey F, et al.
Gastrointest Cancer Res
. 2009 Mar;
1(4):132-8.
PMID: 19262701
Purpose: To evaluate neoadjuvant therapy with weekly paclitaxel/carboplatin plus 5-fluorouracil (5-FU) with conformal radiotherapy in a phase II trial in resectable esophageal carcinoma. Methods: Twenty-four patients with T2-4N0-1M0-1a esophageal carcinoma...
3.
Seung S, Bae J, Solhjem M, Bader S, Gannett D, Hansen E, et al.
Int J Radiat Oncol Biol Phys
. 2008 May;
72(4):1075-81.
PMID: 18486355
Purpose: To review outcomes with intensity-modulated radiation therapy (IMRT) in the community setting for the treatment of nasopharyngeal and oropharyngeal cancer. Methods And Materials: Between April 2003 and April 2007,...
4.
Seung S, Smith J, Molendyk J, Bader S, Phillips M, Regan J, et al.
Semin Oncol
. 2005 Feb;
31(6 Suppl 18):13-9.
PMID: 15726517
This ongoing phase II study is designed to assess the outcomes (survival and failure patterns) of therapy for localized esophageal cancer with conventional dose radiation (50.4 Gy) with concurrent continuous...